Laurion Capital Management’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.2M Hold
300,000
0.06% 38
2025
Q1
$3.39M Hold
300,000
0.09% 53
2024
Q4
$3.15M Hold
300,000
0.06% 62
2024
Q3
$3.14M Hold
300,000
0.04% 59
2024
Q2
$3.07M Hold
300,000
0.04% 92
2024
Q1
$3.11M Buy
+300,000
New +$3.11M 0.03% 149